论文部分内容阅读
目的:观察酚妥拉明联合银杏达莫对慢性肺源性心脏病心衰患者的疗效,为临床治疗提供依据。方法:将90例患者随机分为治疗组和对照组各45例。两组采用常规内科治疗如控制感染、氧疗、强心、利尿等,治疗组在上述治疗基础上加用酚妥拉明20mg+银杏达莫25 mL于10%葡萄糖注射液500 mL中静脉滴注,1次/d,疗程均为10 d。结果:治疗组的疗效、血气分析、血液流变学、功能的改善优于对照组,差异具有统计学意义(P<0.05)。结论:酚妥拉明联合银杏达莫对慢性肺源性心脏病心衰患者具有良好的疗效及安全性,值得临床推广应用。
OBJECTIVE: To observe the curative effect of phentolamine combined with ginkgo dipyridamole on patients with heart failure of chronic cor pulmonale, and provide the basis for clinical treatment. Methods: 90 patients were randomly divided into treatment group and control group, 45 cases each. The two groups were treated with routine medical treatment such as infection control, oxygen therapy, cardiac, diuresis and so on. The treatment group was given phentolamine 20 mg + ginkgo biloba 25 mL on the basis of the above treatment with intravenous infusion of 500 mL of 10% glucose injection , 1 time / d, treatment are 10 d. Results: The curative effect, blood gas analysis, hemorheology and function improvement of the treatment group were better than those of the control group, the difference was statistically significant (P <0.05). Conclusion: Phentolamine combined with ginkgo dipyridamole has good efficacy and safety in patients with heart failure of chronic cor pulmonale, which is worthy of clinical application.